Genpharmasec Ltd
Ticker: GENPHARMA
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
1.77
Market Cap
98.01
Debt/Equity
0.0809
ROE %
1.880
PB
1.5014
Promoter %
29.979
Pledge %
0.000
1Y Rev Growth %
18.378
5Y Rev Growth %
NP Margin %
3.317
NP Margin 5Y Avg %
Trading Reference
1M Return %
-10.204
6M Return %
-12.376
1Y Return %
-41.391
% Away 52W High
144.068
% Away 52W Low
10.625
Daily Volume
433572
Investment Verdict
Hold
Score 70/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 16/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Genpharmasec Ltd is currently trading near a key support level, with the 50-day EMA indicating bullish momentum. If the stock breaks above the recent resistance level, there is a strong potential for upward movement. However, if it falls below the support, it could face significant downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
I
Indian Acrylics Ltd
Indian Acrylics Ltd shows potential in a growing sector, but faces challenges in consistent growth and profitability metrics.
View details
D
Delta Autocorp Ltd
Delta Autocorp Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
I
ICICI Prudential Silver ETF
The ICICI Prudential Silver ETF presents a decent investment opportunity but carries risks associated with market volatility and inconsistent growth.
View details
S
Srei Infrastructure Finance Ltd
Srei Infrastructure Finance Ltd faces significant challenges in profitability and governance, making it a risky investment at this time.
View details
A
Ascom Leasing & Investments Ltd
Ascom Leasing & Investments Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
H
HOAC Foods India Ltd
HOAC Foods India Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
N R Vandana Tex Industries Ltd
The stock presents several risks with inconsistent growth and profitability metrics, making it a risky investment.
View details
P
Paragon Fine & Speciality Chemical Ltd
Paragon Fine & Speciality Chemical Ltd shows decent potential with a few areas of concern that need to be monitored closely.
View details
S
Skyline Millars Ltd
Skyline Millars Ltd presents several risks with inconsistent growth and weak market sentiment, making it a risky investment.
View details
S
Silkflex Polymers (India) Ltd
Silkflex Polymers shows potential in a growing sector but faces challenges in profitability and execution risks. Caution is advised for investors.
View details
S
Shervani Industrial Syndicate Ltd
Shervani Industrial Syndicate Ltd shows several weaknesses in growth, profitability, and market sentiment, making it a risky investment at this time.
View details
I
Ideal Technoplast Industries Ltd
Ideal Technoplast Industries Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability and valuation metrics.
View details
A
Atam Valves Ltd
Atam Valves Ltd shows moderate potential but faces challenges in growth consistency and market sentiment.
View details
S
Shivam Chemicals Ltd
Shivam Chemicals Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Raaj Medisafe India Ltd
The stock presents significant risks with inconsistent growth and profitability metrics, alongside governance concerns.
View details
S
Shine Fashions (India) Ltd
Shine Fashions (India) Ltd shows potential in a growing sector but faces significant risks and challenges that may hinder performance.
View details
Business Overview
Genpharmasec Ltd is a leading player in the Indian pharmaceutical sector, dedicated to delivering high-quality healthcare solutions. Catering to a diverse clientele, including hospitals and healthcare providers, the company focuses on innovative drug development and manufacturing. With a commitment to excellence and compliance with global standards, Genpharmasec is poised to make a significant impact in the healthcare landscape. Their expertise ensures that patients have access to safe and effective medications, reinforcing trust in their brand.
- Leader in pharmaceutical innovation
- Focus on high-quality healthcare solutions
- Serves hospitals and healthcare providers
- Commitment to global compliance standards
- Ensures access to safe and effective medications
Investment Thesis
Genpharmasec Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to peers. The company's strategic initiatives position it well for sustained growth in a competitive market.
- Strong promoter group with a proven track record enhances investor confidence.
- Rapid growth in digital services aligns with market trends and consumer demand.
- Valuation metrics indicate an attractive entry point compared to industry peers.
- Robust business model supports scalability and long-term profitability.
- Commitment to innovation positions Genpharmasec as a market leader.
Opportunity vs Risk
Opportunities
- Growing demand for biotech solutions
- Strong pipeline of innovative products
- Potential for international expansion
- Strategic partnerships with key players
Risks ⚠️
- Regulatory hurdles in drug approval
- High R&D costs impacting profits
- Market competition from established firms
- Dependence on a few key products
Peer Perspective
Genpharmasec Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability; a consistent improvement in profitability could trigger a rerating in the stock.
Future Outlook
Genpharmasec Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market opportunities; however, successful execution and cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does Genpharmasec Ltd do?A: Genpharmasec Ltd focuses on developing and manufacturing pharmaceutical products and biotechnological solutions.
- Q: Is Genpharmasec Ltd a good investment?A: Investment decisions should be based on personal research and financial goals; consult a financial advisor.
- Q: What are the risks of investing in Genpharmasec Ltd?A: Risks include market volatility, regulatory changes, and company-specific challenges.
- Q: How can I buy shares of Genpharmasec Ltd?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: Does Genpharmasec Ltd pay dividends?A: Check the company's latest financial reports for information on dividends, as they may vary.
📊 Stock Investment Checklist (100 Points)
Genpharmasec Ltd • Updated: 2025-09-17 06:43:02
-
10BusinessHighThe sector shows potential but lacks a strong moat.
-
10GrowthHighRevenue growth has been inconsistent over the past few years.
-
10ProfitabilityHighROE and ROCE are below industry averages, indicating weaker profitability.
-
8ValuationHighValuation metrics are higher compared to peers, suggesting overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
5GovernanceGoodPromoter holding is decent, but there are some pledging issues.
-
2DriversLowLimited growth drivers identified, with significant execution risks.
-
0TechnicalsLowWeak market sentiment and poor price action observed.
Final Score & Verdict
Score 48 / 100
• Risky
Genpharmasec Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 65/100
- Growth Potential: 70/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100